Inventor · disambiguated record
Bradford C. Van Wagenen
Also filed as: VAN WAGENEN BRADFORD · VAN WAGENEN BRADFORD C
25 granted patents·5 pending applications·1,356 citations·filing 1993–2012
97Inventor score
Files withNPS PHARMA INC20ASTRAZENECA AB3BRIGHAM & WOMENS HOSPITAL2VAN WAGENEN BRADFORD2ARTMAN LINDA D1
Top patents by PatentIndex Score
30 records- 0198US6660753B2Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2002·Granted Dec 9, 2003·160 cites·58 claims
- 0296US6211244B1Calcium receptor-active compoundsNPS PHARMA INC·Filed 1995·Granted Apr 3, 2001·251 cites·46 claims
- 0394US6429207B1Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseasesNPS PHARMA INC·Filed 2000·Granted Aug 6, 2002·67 cites·23 claims
- 0494US6011068ACalcium receptor-active moleculesBRIGHAM & WOMENS HOSPITAL·Filed 1994·Granted Jan 4, 2000·137 cites·103 claims
- 0593US6031003ACalcium receptor-active moleculesNPS PHARMA INC·Filed 1995·Granted Feb 29, 2000·151 cites·145 claims
- 0691US6313146B1Calcium receptor-active moleculesNPS PHARMA INC·Filed 1995·Granted Nov 6, 2001·104 cites·55 claims
- 0789US6001884ACalcium receptor-active moleculesNPS PHARMA INC·Filed 1995·Granted Dec 14, 1999·100 cites·44 claims
- 0889US5981599AInorganic ion receptor active compoundsNPS PHARMA INC·Filed 1997·Granted Nov 9, 1999·70 cites·27 claims
- 0986US7868008B2Substituted isoindolones and their use as metabotropic glutamate receptor potentiatorsASTRAZENECA AB·Filed 2006·Granted Jan 11, 2011·11 cites·4 claims
- 1082US7807706B2Metabotropic glutamate-receptor-potentiating isoindolonesASTRAZENECA AB·Filed 2006·Granted Oct 5, 2010·6 cites·9 claims
- 1182US7202261B2Calcilytic compoundsNPS PHARMA INC·Filed 2004·Granted Apr 10, 2007·13 cites·31 claims
- 1282US6818660B2Calcilytic compoundsNPS PHARMA INC·Filed 2001·Granted Nov 16, 2004·14 cites·15 claims
- 1382US6022894AMethod of using calcilytic compoundsNPS PHARMA INC·Filed 1997·Granted Feb 8, 2000·51 cites·30 claims
- 1482US5858684AMethod of screening calcium receptor-active moleculesBRIGHAM & WOMENS HOSPITAL·Filed 1995·Granted Jan 12, 1999·59 cites·48 claims
- 1581US7968570B2Isoindolone compounds and their use as metabotropic glutamate receptor potentiatorsASTRAZENECA AB·Filed 2005·Granted Jun 28, 2011·6 cites·4 claims
- 1680US7053104B2Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseasesNPS PHARMA INC·Filed 2002·Granted May 30, 2006·9 cites·23 claims
- 1777US6710088B2Inorganic ion receptor-active compoundsNPS PHARMA INC·Filed 2002·Granted Mar 23, 2004·8 cites·26 claims
- 1873US6432656B1Calcilytic compoundsNPS PHARMA INC·Filed 1999·Granted Aug 13, 2002·41 cites·9 claims
- 1971US6521667B1Calcilytic compoundsNPS PHARMA INC·Filed 1998·Granted Feb 18, 2003·28 cites·12 claims
- 2069US6342532B1Inorganic ion receptor active compoundsNPS PHARMA INC·Filed 1999·Granted Jan 29, 2002·22 cites·21 claims
- 2166US5506268AUse of isovaleramide as a mild anxiolytic and sedative agentNPS PHARMA INC·Filed 1993·Granted Apr 9, 1996·15 cites·15 claims
- 2261US6294531B1Calcilytic compoundsSMITHKLINE BEECHAM CORP·Filed 1998·Granted Sep 25, 2001·21 cites·8 claims
- 2353US6051610ACompounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseasesNPS PHARMA INC·Filed 1999·Granted Apr 18, 2000·8 cites·24 claims
- 2451US2006229470A1Calcium receptor-active moleculesNPS PHARMA INC·Filed 2005·Application pending·0 cites
- 2550US2013190407A1Calcium receptor-active moleculesNPS PHARMA INC·Filed 2012·Application pending·0 cites
- 2645US5763494APharmaceutical compositions comprising isovaleramideNPS PHARMA INC·Filed 1996·Granted Jun 9, 1998·4 cites·7 claims
- 2743US2011166155A1Substituted Isoindolones and Their Use as Metabotropic Glutamate Receptor PotentiatorsVAN WAGENEN BRADFORD·Filed 2011·Application pending·0 cites
- 2843US2007249702A1Calcilytic compoundsDEL MAR ERIC G·Filed 2007·Application pending·0 cites
- 2939US2006025477A1Analogs of isovaleramide, a pharmaceutical composition including the same, and a method of treating central nervous system conditions or diseasesARTMAN LINDA D·Filed 2005·Application pending·0 cites
- 3037US8153638B2Metabotropic glutamate-receptor-potentiating isoindolonesVAN WAGENEN BRADFORD·Filed 2010·Granted Apr 10, 2012·0 cites·3 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →